PGA
AMGN icon

Premia Global Advisors’s Amgen AMGN Stock Holding History

Premia Global Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-989
Closed -$187K – 73
2019
Q1 		$187K Buy
+989
New +$189K 0.19% 120
2018
Q2 		– Sell
-989
Closed -$168K – 193
2018
Q1 		$168K Sell
989
-1,630
-62% -$299K 0.15% 147
2017
Q4 		$451K Buy
+2,619
New +$463K 0.44% 36

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Premia Global Advisors's AMGN Position: Q2 2019 in Review

Premia Global Advisors sold out of Amgen (AMGN) in Q2 2019, closing a stake of 989 shares — an estimated $187K sold.

Premia Global Advisors first reported a position in AMGN in Q4 2017 and held it in 3 quarters. The position peaked at $451K in Q4 2017. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Premia Global Advisors reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Premia Global Advisors sold 989 Amgen shares in Q2 2019, an estimated $187K.
  • Premia Global Advisors first reported a position in Amgen in Q4 2017 and held it in 3 quarters.
  • Premia Global Advisors's Amgen position peaked at $451K in Q4 2017.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.